Clinical Trial Update: A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety of applying Fibroblast Growth Factor-2 with periodontal surgery for periodontitis in Japan has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• Fibroblast Growth Factor-2 (FGF-2) (fibroblast growth factor-2)

Snippet

Sponsor: Kaken Pharmaceutical | Conditions: Periodontitis | Phase 3 | Status: COMPLETED